Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Molecular Partners ADR | MOLN | Dec 24, 2024 | 5.31 | -2.39 |
Molecular Templates | MTEM | Dec 24, 2024 | 0.11 | -23.43 |
Moleculin Biotech | MBRX | Dec 24, 2024 | 1.82 | +5.20 |
Molina Healthcare | MOH | Dec 24, 2024 | 295.19 | +0.23 |
Molson Coors B | TAP | Dec 24, 2024 | 58.60 | +0.05 |
Molson Coors Beverage Company A | TAP-A | Dec 24, 2024 | 58.51 | -2.66 |
Momentus A | MNTS | Dec 24, 2024 | 7.65 | -4.14 |
Monarch Casino & Resort | MCRI | Dec 24, 2024 | 78.15 | +0.55 |
Monday.com | MNDY | Dec 24, 2024 | 234.80 | +1.27 |
Mondee | MOND | Dec 24, 2024 | 0.20 | 0.00 |
Mondelez International A | MDLZ | Dec 24, 2024 | 60.00 | +1.21 |
Moneyhero | MNY | Dec 24, 2024 | 1.08 | -1.82 |
MoneyLion A | ML | Dec 24, 2024 | 86.64 | +0.45 |
MongoDB A | MDB | Dec 24, 2024 | 243.00 | +0.03 |
Monogram Technologies | MGRM | Dec 24, 2024 | 2.59 | +3.60 |
Monolithic Power Systems | MPWR | Dec 24, 2024 | 619.58 | +0.37 |
Monopar Therapeutics | MNPR | Dec 24, 2024 | 22.05 | -8.13 |
Monro | MNRO | Dec 24, 2024 | 25.19 | +0.20 |
Monroe Capital | MRCC | Dec 24, 2024 | 8.14 | +0.12 |
Monster Beverage | MNST | Dec 24, 2024 | 52.51 | +1.25 |
Montauk Renewables | MNTK | Dec 24, 2024 | 3.77 | -0.26 |
Monte Rosa Therapeutics | GLUE | Dec 24, 2024 | 7.05 | -1.26 |
Montrose Environmental Group | MEG | Dec 24, 2024 | 17.25 | +4.55 |
Moodys | MCO | Dec 24, 2024 | 480.38 | +1.40 |
Moog A | MOG-A | Dec 24, 2024 | 197.35 | +1.95 |
Moog B | MOG-B | Dec 24, 2024 | 189.87 | 0.00 |
Moolec Science | MLEC | Dec 24, 2024 | 0.76 | -5.48 |
MoonLake Immunotherapeutics | MLTX | Dec 24, 2024 | 52.67 | +1.02 |
Morgan Stanley | MS | Dec 24, 2024 | 127.06 | +2.10 |
Morgan Stanley China A Share Fund | CAF | Dec 24, 2024 | 12.59 | +1.29 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.